- Home
- EVAX vs BRN Comparison
EVAX vs BRN Comparison
Compare EVAX & BRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVAX
- BRN
- Stock Information
- Founded
- EVAX 2008
- BRN 1956
- Country
- EVAX Denmark
- BRN United States
- Employees
- EVAX N/A
- BRN N/A
- Industry
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- BRN Oil & Gas Production
- Sector
- EVAX Health Care
- BRN Energy
- Exchange
- EVAX Nasdaq
- BRN Nasdaq
- Market Cap
- EVAX 16.3M
- BRN 17.6M
- IPO Year
- EVAX 2021
- BRN N/A
- Fundamental
- Price
- EVAX $1.69
- BRN $1.62
- Analyst Decision
- EVAX Strong Buy
- BRN
- Analyst Count
- EVAX 2
- BRN 0
- Target Price
- EVAX $10.00
- BRN N/A
- AVG Volume (30 Days)
- EVAX 65.8K
- BRN 20.4K
- Earning Date
- EVAX 05-27-2025
- BRN 05-13-2025
- Dividend Yield
- EVAX N/A
- BRN N/A
- EPS Growth
- EVAX N/A
- BRN N/A
- EPS
- EVAX N/A
- BRN N/A
- Revenue
- EVAX $3,344,000.00
- BRN $20,046,000.00
- Revenue This Year
- EVAX $102.45
- BRN N/A
- Revenue Next Year
- EVAX $200.44
- BRN N/A
- P/E Ratio
- EVAX N/A
- BRN N/A
- Revenue Growth
- EVAX 4480.82
- BRN N/A
- 52 Week Low
- EVAX $1.61
- BRN $1.26
- 52 Week High
- EVAX $22.05
- BRN $3.20
- Technical
- Relative Strength Index (RSI)
- EVAX 36.47
- BRN 48.22
- Support Level
- EVAX $1.67
- BRN $1.26
- Resistance Level
- EVAX $1.97
- BRN $1.79
- Average True Range (ATR)
- EVAX 0.12
- BRN 0.08
- MACD
- EVAX 0.04
- BRN -0.00
- Stochastic Oscillator
- EVAX 22.22
- BRN 33.33
About EVAX Evaxion Biotech
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.
About BRN Barnwell Industries Inc.
Barnwell Industries Inc is an oil and gas firm. Its areas of operations include acquiring, developing, producing, and selling oil and natural gas. The company acquires and develops crude oil and natural gas assets. The company's operating segment includes Oil and natural gas, Contract drilling, Land investment, and Others. It generates maximum revenue from the Oil and natural gas segment. It operates in two geographical segments the United States, which generates a majority of revenue, and Canada.